You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
TP63
Tumor protein 63

Protein Summary
Description
Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter. This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins ...more
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000264731
  • ENSP00000264731
  • ENSG00000073282
  • ENST00000320472
  • ENSP00000317510
  • ENST00000354600
  • ENSP00000346614
  • ENST00000392460
  • ENSP00000376253
  • ENST00000392461
  • ENSP00000376254
  • ENST00000392463
  • ENSP00000376256
  • ENST00000418709
  • ENSP00000407144
  • ENST00000437221
  • ENSP00000392488
  • ENST00000440651
  • ENSP00000394337
  • ENST00000449992
  • ENSP00000387839
  • ENST00000456148
  • ENSP00000389485

Symbol
  • KET
  • P63
  • P73H
  • P73L
  • TP73L
  • AIS
  • KET
  • LMS
  • NBP
  • RHS
  • p40
  • p51
  • p63
  • EEC3
  • OFC8
  • p73H
  • p73L
  • SHFM4
  • TP53L
  • TP73L
  • p53CP
  • TP53CP
  • B(p51A)
  • B(p51B)
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
biological process
1
protein domain
0.97
molecular function
0.94
transcription factor perturbation
0.94
trait
0.93


IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 387.67   (req: < 5)
Gene RIFs: 832   (req: <= 3)
Antibodies: 794   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 387.67   (req: >= 5)
Gene RIFs: 832   (req: > 3)
Antibodies: 794   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 65
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0